clofibrate significantly lowered very low density lipoprotein ( vldl ) associated cholesterol in all three hyperlipoproteinemia phenotypes , and it also lowered vldl triglycerides in type iv , while increasing high density lipoprotein ( hdl ) cholesterol in type iia patients .
C0008377
cholesterol
C0023822
high density lipoprotein